ATAC Resources Ltd. (CVE:ATC), a gold junior, jumped after releasing assay results from the Rackla Gold Property in the Yukon
Sean Mason | August 29, 2017 | SmallCapPower
Positive momentum continued for a gold junior Tuesday following the release of additional drill results. Here’s some small stocks making big moves on Tuesday, August 29, 2017 (as of 4 pm EST):
ATAC Resources Ltd. (TSXV: ATC) shares climbed 6% to $0.68 on Tuesday after the gold junior announced results of an additional four diamond drill holes from the Conrad and Osiris Zones within the Osiris Project at the Rackla Gold Property in the Yukon, which included 12.50 metres of 20.78 g/t gold.
As well, shares of Prometic Life Sciences Inc. (TSX: PLI) surged 25% to $1.50 as the biopharmaceutical company said the U.S Food and Drug Administration (FDA) has granted a Rare Pediatric Disease Designation to Prometic’s Ryplazimä, a plasminogen replacement therapy for the treatment of patients with congenital plasminogen deficiency.
Dolly Varden Silver Corporation (TSXV: DV), meanwhile, reported results from drilling on the Dolly Varden Silver Project in British Columbia, which included 6.72 metres grading 1,272 g/t silver equivalent. Dolly Varden Silver stock moved up 14% to $0.80 following the announcement.
Finally, YANGAROO Inc. (TSXV: YOO) shares jumped 50% to $0.165 after the digital media management and distribution company announced that its second-quarter revenue increased 75% to $2,026,731.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: